Grant: Collaborative Research and Development Grants
University of Guelph
$33,600.00
Applying recombinant technologies to define the secretome of M.a. paratuberculosis for the discovery of potential immunogens and diagnostic reagents
FY 2010-11
Summary
Johne's disease (JD) is an incurable chronic and wasting disease affecting ruminant animals such as cows, goats, sheep elk and deer. Animals become infected by eating live Mycobacterium avium subspecies paratuberculosis (or MAP) bacteria in food, water or milk. JD affects herds in all regions of Canada with up to 40% of dairy herds reporting an infected animal. Herds with infected animals suffer very significant economic looses from decrease in milk production, fertility and increased culling of sick animals. There is also concern regarding the possible association between MAP and some cases of Crohn's disease in humans. These concerns will continue until there is definitive proof against such a link but it would be devastating to the cattle industry if such link were established. Currently there are no vaccines that protect animals against infection and no treatments that prevent or reduce MAP shedding in feces and milk. However, JD can be controlled by stopping the cow-to-cow spread of MAP and this goal can achieved by identifying and removing infected animals before they start shedding the bacterium. However, the current diagnostic tests lack the sensitivity and specificity to detect animals with early stage (or subclinical) disease. To develop such tests, research effort is needed to build on our understanding of the biology and genetics of MAP bacteria and to discover MAP components that can be used to design MAP-specific diagnostic assays and possibly vaccines. To date only a few MAP proteins have been identified and fully characterized. The purpose of our study is to use current recombinant technologies to characterize the proteins secreted by MAP. Secreted proteins make first contact with the host, determine the course of infection and contain the antigens recognized by the host immune system to induce antibody and cell mediated responses. Characterizing secreted proteins also has practical application in the discovery of novel reagents for profiling host immune responses, diagnosis of infection, and differentiation between vaccinated and infected hosts.
Program
Collaborative Research and Development Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
372380-2008
Name nom
Mutharia, Lucy
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
33600
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
2
Nb partie
3
Application title
Applying recombinant technologies to define the secretome of M.a. paratuberculosis for the discovery of potential immunogens and diagnostic reagents
Keyword
NSERC
Application summary
Johne's disease (JD) is an incurable chronic and wasting disease affecting ruminant animals such as cows, goats, sheep elk and deer. Animals become infected by eating live Mycobacterium avium subspecies paratuberculosis (or MAP) bacteria in food, water or milk. JD affects herds in all regions of Canada with up to 40% of dairy herds reporting an infected animal. Herds with infected animals suffer very significant economic looses from decrease in milk production, fertility and increased culling of sick animals. There is also concern regarding the possible association between MAP and some cases of Crohn's disease in humans. These concerns will continue until there is definitive proof against such a link but it would be devastating to the cattle industry if such link were established. Currently there are no vaccines that protect animals against infection and no treatments that prevent or reduce MAP shedding in feces and milk. However, JD can be controlled by stopping the cow-to-cow spread of MAP and this goal can achieved by identifying and removing infected animals before they start shedding the bacterium. However, the current diagnostic tests lack the sensitivity and specificity to detect animals with early stage (or subclinical) disease. To develop such tests, research effort is needed to build on our understanding of the biology and genetics of MAP bacteria and to discover MAP components that can be used to design MAP-specific diagnostic assays and possibly vaccines. To date only a few MAP proteins have been identified and fully characterized. The purpose of our study is to use current recombinant technologies to characterize the proteins secreted by MAP. Secreted proteins make first contact with the host, determine the course of infection and contain the antigens recognized by the host immune system to induce antibody and cell mediated responses. Characterizing secreted proteins also has practical application in the discovery of novel reagents for profiling host immune responses, diagnosis of infection, and differentiation between vaccinated and infected hosts.